Question reference: S6W-17888
- Date lodged: 11 May 2023
-
Current status: Answered by Jenni Minto on 22 May 2023
Question
To ask the Scottish Government what action is being taken to tackle the reported increasing prevalence of (a) inflammatory bowel disease, (b) Crohn's disease and (c) colitis.
Answer
The Scottish Government is committed to ensuring that all people in Scotland living with Inflammatory bowel diseases (IBD), including Crohn's disease and colitis, are able to access the best possible care and support, and benefit from healthcare services that are safe, effective and put people at the centre of their care.
We have funded the Modernising Patient Pathways Programme (MPPP) which has a specific workstream continuing to promote improvements in IBD care for patients across Scotland in partnership with third sector and people with lived experience. Scotland’s national IBD Steering Group has identified priority areas for work over the next two years. This includes consideration of referral pathways and models of IBD care to drive a more standardised and equitable service across Scotland to ensure that people receive appropriate help when they need it.
We also fund NHS Research Scotland which is a partnership between Health Boards and the Chief Scientists Office of Scottish Government to ensure that NHS Scotland provides the best environment to support clinical research. This includes a gastroenterology speciality group which leads on research into Crohn’s Disease and Ulcerative Colitis, with a focus on a range of areas including early diagnosis of these conditions and clinical trials for new treatments. More information is available on the NHS Research Scotland website: https://www.nhsresearchscotland.org.uk/research-areas/gastroenterology.